Latest news with #Disruptor
Time of India
2 days ago
- Automotive
- Time of India
Nitin Gadkari inaugurates OPG Mobility's Ferrato EV dealership in Nagpur
In a boost to India's electric mobility drive, OPG Mobility (formerly Okaya EV) inaugurated its new Ferrato two-wheeler dealership, Vajra E Scooter, at 3-Nal Chowk, Gandhibagh in Nagpur. The showroom was inaugurated by Union Minister for Road Transport and Highways, Nitin Gadkari , underscoring the government's push for cleaner, sustainable transport solutions. The dealership offers a complete sales and service experience and showcases Ferrato's full lineup, including high-speed scooters like DEFY 22 and Faast F-series, low-speed Freedum models, and the premium electric motorcycle, Disruptor. Customers buying through Flipkart will enjoy special discounts. Founder OM Prakash Gupta said the launch marks a key milestone in expanding the company's presence in central India, with plans to scale into western and southern markets. With a focus on innovation, affordability, and after-sales service, OPG Mobility is rapidly expanding its footprint to meet India's growing demand for electric two-wheelers , the company's statement said.
CNBC
3 days ago
- Business
- CNBC
CNBC Reveals Thirteenth Annual CNBC Disruptor 50
ENGLEWOOD CLIFFS, N.J., June 10, 2025− CNBC, First in Business Worldwide, today announced the thirteenth annual CNBC Disruptor 50, a ranked list of fast-growing, innovative private startups advancing breakthrough technology to identify new market opportunities and deliver solutions across a multitude of sectors. The companies on this year's Disruptor 50 list have a combined valuation of $798 billion and have collectively raised more than $127 billion in funding to date. The top five companies on the 2025 CNBC Disruptor 50 list – Anduril, OpenAI, Databricks, Anthropic and Canva – alone have a combined valuation of just under $500 billion. This is more than the combined total valuation of almost every past Disruptor 50 list of the last 12 years. $300 billion of this value is from OpenAI, the company that sparked a global arms race for new artificial intelligence capabilities and topped both the 2023 and 2024 Disruptor 50 lists. CNBC revealed the list across the network's platforms and is featuring special coverage throughout Business Day programming and on CNBC Digital this week. special report, features complete profiles of all 50 companies, including a spotlight on the number one Disruptor, a look at the emerging trends making news within many of the sectors on the list, as well as an explanation of how CNBC selected and ranked the companies that made the final cut. CNBC will also track each company's progress throughout the year, expecting many to become perennial Disruptor 50 companies. Following are the top ten 2025 CNBC Disruptor 50 companies: 1. Anduril 2. OpenAI 3. Databricks 4. Anthropic 5. Canva 6. Ramp 7. Flock Safety 8. AlphaSense 9. Octopus Energy 10. Stripe For more information regarding the CNBC Disruptor 50, including the full list, interviews, in-depth analysis and original digital video, visit Stay up to date on the latest news regarding Disruptor 50 companies by subscribing to CNBC's weekly newsletter at Follow @CNBCDisruptors on X and Instagram and join the conversation using the hashtag #Disruptor50. The CNBC Disruptor 50 was selected by CNBC and editorial staff using a proprietary blend of quantitative and qualitative information submitted by the nominated companies. Disruptor 50 data partners PitchBook and IBISWorld provided additional quantitative input. CNBC's Disruptor 50 Advisory Council, a group of 50 leading thinkers in the field of innovation and entrepreneurship from around the world, weighted the quantitative criteria and provided additional analysis of qualitative information. CNBC's Disruptor 50 VC Advisory Board also leveraged the expertise of leading venture capital firms and their investors. Each member of the board assessed a small group of finalists as an additional component of the qualitative review; however, they were not permitted to provide an assessment of any company in their firm's own portfolios.
CNBC
3 days ago
- Business
- CNBC
29. Rippling
Founders: Parker Conrad (CEO), Prasanna SankarLaunched: 2016Headquarters: San FranciscoFunding: $1.8 billion (PitchBook)Valuation: $16.8 billion (PitchBook)Key Technologies: Artificial intelligence, cloud computing, low code/no code softwareIndustry: Enterprise technologyPrevious appearances on Disruptor 50 list: 1 (No. 14 in 2023) Workforce management company Rippling aims to combine the numerous systems that manage employees — everything from payroll and benefits to devices and compliance — into a single, integrated platform. With Rippling, onboarding a new employee can take less than two minutes. That includes setting up email accounts, enrolling in insurance, and issuing work devices. The company targets customers from startups to mid-sized enterprises across North America, Europe, and Asia-Pacific, with up to 10,000 employees. Rippling has been extending the platform's employee management features over the past year. Among the most notable: Talent Signal, an AI-powered tool that analyzes new hires' work and gives managers a second opinion on how they're performing. Rippling also introduced an employee scheduling tool that can customize complicated hourly work schedules based on demand, certifications, and hundreds of other data points. That tool, launched in October, became the company's fastest product to reach $1 million in sales. But the year wasn't without controversy. In March, Rippling filed a high-profile lawsuit against Deel, a rival in the global workforce space and former Disruptor, accusing the company of corporate espionage. According to Rippling's filings, a former employee acted as a mole for Deel, accessing confidential data about customers, quotes, sales calls, demos and support requests in internal Slack repositories. The company claims he also found and downloaded Rippling's guidance on how to go up against Deel for prospective business, according to the legal filing. In response, Deel recently unleashed its own allegations of bad behavior by Rippling. Despite the legal drama, Rippling has continued to grow, with annual revenue increasing at a rate of more than 30%. The company raised $450 million in a recent fundraising round, and committed to buying an additional $200 million worth of shares from current and previous employees — a morale-boosting move amid continued layoffs in tech and many sector valuations that haven't recovered since the startup downturn of 2022-2023. Rippling has not had recent layoffs and the latest round of funding saw its valuation rise by more than $3 billion. The company also opened new offices: a new European headquarters in Dublin; its first Asia Pacific office in Sydney; and moved into a new office in San Francisco. In a market fragmented by numerous niche solutions, Rippling is betting that its all-in-one approach will allow it to outmaneuver Deel and other startups, as well as incumbents ADP and Paychex. CEO Parker Conrad told CNBC in a May interview that he thinks the legal drama with Deel may be helping it win more business. "I think it's too early to say, looking at the data, how all of this is going to evolve from a market perspective, but certainly we see some companies that have said, 'Hey, we're talking to Rippling because of this,'" Conrad said.
CNBC
3 days ago
- Business
- CNBC
26. Iambic Therapeutics
Founders: Tom Miller (CEO), Fred ManbyLaunched: 2020Headquarters: San Diego, CaliforniaFunding: $220 millionValuation: N/AKey Technologies: Artificial intelligence, cloud computing, deep neural networks/deep learning, generative AI, machine learning, robotics, quantum computingIndustry: BiotechPrevious appearances on Disruptor 50 list: 0 It can take 10-15 years for today's biopharmaceutical companies to bring new drugs all the way through discovery and clinical trial. San Diego-based Iambic Therapeutics' AI-driven platform can accelerate the pace of drug discovery and development, enabling drug development in just a few years. The company has novel medications in its pipeline to treat breast cancer and other HER2 cancers, and recently formed a research collaboration with pharmaceutical giant Lundbeck for a small molecule therapeutic to treat migraines. By predicting how its new molecules will interact with human systems, Iambic's technology can also reduce the need for clinical trials. The company was originally called Entos, and was founded when CEO Thomas Miller, a theoretical chemist and professor at California Institute of Technology, teamed up with longtime collaborator Fred Manby. In its first iteration, the company worked on making better chemical predictions across many industries and worked with companies including Toyota and Procter & Gamble. But the founders saw applications for their work in what's called small molecule drug discovery. Small molecule drugs, often synthesized chemically, target specific proteins or cellular pathways. Iambic's platform for drug discovery is called Enchant. The company says it provides high-confidence predictions in data-poor situations, such as early-stage and clinical-stage drug programs. "(Cancer) is an area of huge need," Miller told an interviewer for the California Institute of Technology in 2022. "It's an incredibly fast, quickly advancing disease. Many people are afflicted by it. There's many varieties of it. It is the combination of those things that means that if you have the ability to design a new drug, there's a way to … have a relatively fast timescale to advance that to the point where it's in human trials." Rather than selling its drug-discovery services and software to pharmaceutical companies, Iambic has focused on producing its own drugs. "Instead of running around, trying to convince people that this software is so great, and they should buy it, you can actually just use it and execute with it, and actually make better molecules. Then those molecules can stand on their own two feet," Miller said. In 2024, Iambic completed a B round of funding, with investors including OrbiMed, Nvidia and Sequoia Capital, and announced a collaboration with Nvidia, which has been teaming up as a venture investor with many startups across sectors using AI, including, for example, agtech Disruptor Carbon Robotics. Iambic also moved into a new headquarters in San Diego last year and took its headcount to about 100, enabling the company to run experiments on thousands of newly discovered molecules each week. It also announced an update to NeuralPLexer, which predicts protein-ligand structures, and published data in Nature Machine Intelligence showing that NeuralPLexer outperformed AlphaFold, the Nobel Prize in Chemistry winner developed by Google's DeepMind. Iambic also hired its first CFO, Michael Secora, who previously worked at publicly held Recursion.
CNBC
3 days ago
- Business
- CNBC
25. Abnormal AI
Founders: Evan Reiser (CEO), Sanjay JeyakumarLaunched: 2018Headquarters: Las Vegas, NevadaFunding: $546 millionValuation: $5.1 billionKey Technologies: Artificial intelligence, machine learningIndustry: CybersecurityPrevious appearances on Disruptor 50 list: 1 (No. 47 in 2024) Abnormal AI uses artificial intelligence to help big companies counter an old but dangerous problem: socially engineered attacks delivered via email, exploiting human vulnerability. These remain one of the largest cybersecurity threats. Unlike traditional cybersecurity that identifies markers of compromise, Abnormal Security uses artificial intelligence to create baselines for users' normal behavior, then uses the baseline to filter out malicious activity. Examples are emails sent at the wrong time of the day, with words that aren't right for that user, or an uncommon contact reaching out in a suspicious manner. Humans backstop the AI filter and respond to threats. The company can also detect attacks that bypass multi-factor authentication and guard against account takeovers. In 2024, Abnormal hit several key milestones: 100% year over year growth, $200 million in annual recurring revenue, and over 3,000 customers across 35 countries. The company has been expanding across Europe and to Japan, and has grown its headcount by 70% to more than 1,000. Abnormal has continued to roll out new products, including an AI system that works across cloud applications, including email and collaboration apps, and a security mailbox that automates user-reporting phishing attacks. This year, the company launched autonomous AI agents that offer employees personalized training replacing generic cybersecurity compliance modules, using actual attacks from the past to create simulations that train users. With systems designed for companies with thousands of employees, Abnormal AI says more than 20% of the Fortune 500 use its services. In April, the company secured a key authorization from the federal government to compete for contracts in the public sector. Last August, Abnormal announced a $250 million Series D funding round led by Wellington Management. Other investors include CrowdStrike Falcon Fund and Greylock Partners, where CEO and serial entrepreneur Evan Reiser incubated the company.
